Clinical study of GCP-006

JRCT ID: jRCT1051240034

Registered date:16/05/2024

Basic Information

• Recruitment status: Complete
• Health condition(s) or Problem(s) studied: breast cancer
• Date of first enrollment: 30/05/2022
• Study type: Observational

Outcome(s)

• Primary Outcome: The usefulness is evaluated by comparing the measurement results (fluorescence intensity) of GCP-006 with the results of histopathological examination using a permanent pathological specimen.

Key inclusion & exclusion criteria

• Age minimum: >= 20age old
• Age maximum: Not applicable
• Gender: Female

Include criteria

1. Women aged 20 years or older at the time of informed consent
2. Patients with a confirmed diagnosis of breast cancer who are scheduled to undergo total or partial mastectomy
3. Patients who understood the information included in the informed consent document and have provided written consent through themselves or a legal representative prior to enrollment in the study

Exclude criteria

1. Those participating in another clinical study or clinical research study at the time of informed consent
2. Those considered ineligible to participate in this study for medical reasons by the collaborative research principal investigator, etc.
3. Those with a preoperative diagnosis of mucinous carcinoma

Related Information

• Primary Sponsor: Development department responsible party
• Source(s) of Monetary Support: GORYO Chemical, Inc.